SMART Health Cards: Terminology
0.1.0
- ci-build
SMART Health Cards: Terminology - Local Development build (v0.1.0). See the Directory of published versions
| Official URL: https://github.com/dvci/shc-terminology/ConceptMap/covid-mapping-cvx-air | Version: 0.1.0 | |||
| Draft as of 2021-09-22 | Responsible: VCI |
Realm: |
Computable Name: CovidCVXAirConceptMap | |
Copyright/Legal: Creative Commons 0 |
||||
A Mapping between CVX and AIR Codes for Covid vaccinations. This mapping is bi-directional - one group for each direction
Mapping from (not specified) to (not specified)
DRAFT. Published on 2021-09-22 by VCI (VCI: https://vci.org). Creative Commons 0
A Mapping between CVX and AIR Codes for Covid vaccinations. This mapping is bi-directional - one group for each direction
| Source Code | Relationship | Target Code |
Mapping from https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats|20210222 to PH_VaccinesAdministeredCVX_CDC_NIP | ||
| COVAST (COVID-19 Vaccine AstraZeneca) | is equivalent to | 210 (COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL) |
| COMIRN (Pfizer Comirnaty) | is equivalent to | 208 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose) |
| MODERN (Moderna Spikevax) | is equivalent to | 207 (COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose) |
| Source Concept Details | Relationship | Target Concept Details | |||
| Code from PH_VaccinesAdministeredCVX_CDC_NIP | Code from https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats|20210222 | ||||
| 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | is equivalent to | COVAST | COVID-19 Vaccine AstraZeneca | |
| 208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | is equivalent to | COMIRN | Pfizer Comirnaty | |
| 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | is equivalent to | MODERN | Moderna Spikevax | |
| 211 | COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL | (not mapped) | |||
| 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | (not mapped) | |||
| 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | (not mapped) | |||
| 217 | (not mapped) | ||||
| 218 | (not mapped) | ||||
| 219 | (not mapped) | ||||
| 500 | (not mapped) | ||||
| 501 | (not mapped) | ||||
| 502 | (not mapped) | ||||
| 503 | (not mapped) | ||||
| 504 | (not mapped) | ||||
| 505 | (not mapped) | ||||
| 506 | (not mapped) | ||||
| 507 | (not mapped) | ||||
| 508 | (not mapped) | ||||
| 509 | (not mapped) | ||||
| 510 | (not mapped) | ||||
| 511 | (not mapped) | ||||